AL 082D06游離態(tài)
| 中文名稱 | AL 082D06游離態(tài) |
|---|---|
| 中文同義詞 | AL 082D06游離態(tài);化合物AL082D06;4,4'-((2-氯-5-硝基苯基)亞甲基)雙(N,N-二甲基苯胺);化合物AL082D06,10 MM DMSO 溶液;256925-03-8;AL082D06;抑制劑AL 082D06;抑制劑AL 082D06 |
| 英文名稱 | D 06 |
| 英文同義詞 | AL 082D06;AL082D06;AL-082D06;D 06;AL 082D06(D-06);4,4'-[(2-Chloro-5-nitrophenyl)methylene]bis[N,N-dimethylbenzenamine];AL-082D06; D06; D-06;AL082D06;4-[(2-Chloro-5-nitrophenyl)-[4-(dimethylamino)phenyl]methyl]-N,N-dimethylaniline |
| CAS號 | 256925-03-8 |
| 分子式 | C23H24ClN3O2 |
| 分子量 | 409.91 |
| EINECS號 | |
| 相關(guān)類別 | 小分子抑制劑;小分子抑制劑,天然產(chǎn)物;Inhibitors |
| Mol文件 | 256925-03-8.mol |
| 結(jié)構(gòu)式 | ![]() |
AL 082D06游離態(tài) 性質(zhì)
| 沸點(diǎn) | 543.7±50.0 °C(Predicted) |
|---|---|
| 密度 | 1.232±0.06 g/cm3(Predicted) |
| 儲存條件 | 2-8°C |
| 溶解度 | DMSO:6.25(最大濃度 mg/mL);15.25(最大濃度 mM) DMF:10.0(最大濃度 mg/mL);24.4(最大濃度 mM) DMF:PBS ( pH 7.2) (1:2):0.33(最大濃度 mg/mL);0.81(最大濃度 mM) |
| 形態(tài) | 結(jié)晶固體 |
| 酸度系數(shù)(pKa) | 5.36±0.24(Predicted) |
| 顏色 | 淺黃至黃色 |
| Target | Value |
|
Glucocorticoid receptor
() | 210 nM(Ki) |
AL 082D06 (D06) binds specifically to GR with nanomolar affinity. Addition of AL 082D06 causes a dose-dependent decrease in transcriptional activation from the MMTV:Luc reporter stimulated with half-maximal DEX concentrations. AL 082D06 acts to antagonize reporter activity using several glucocorticoid-responsive promoter- reporter systems including the 3-kb tyrosine amino transferase (TAT) promoter and less complex promoters comprised of isolated glucocorticoid response element (GRE) sequences. AL 082D06 competes with 3 H-Dex for baculovirus-expressed GR with nanomolar affinity. Other intracellular receptors (AR, ER, PR, and MR) have no affinity for AL 082D06 in a similarly structured binding assay with the appropriate receptor and tritiated ligand (>2500 nM). AL 082D06 has no activation efficacy on the progesterone, androgen, mineralocorticoid, retinoid, glucocorticoid, or estrogen receptors. AL 082D06 is very efficacious at antagonizing GR activity but exhibits much weaker efficacy when tested against the other steroid receptors in contrast to the reference antagonists used as controls.
安全信息
| 更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價(jià)格 |
|---|---|---|---|---|---|
| 2026/06/05 | HY-15709 | AL 082D06游離態(tài) AL 082D06 | 256925-03-8 | 2mg | 2000元 |
| 2026/06/05 | HY-15709 | AL 082D06游離態(tài) AL 082D06 | 256925-03-8 | 5mg | 3000元 |
